Arcutis Biotherapeutics (ARQT) Cash & Equivalents (2020 - 2026)
Arcutis Biotherapeutics (ARQT) posted quarterly Cash & Equivalents of $308000.0 for Q1 2026, down 50.08% year-over-year from $617000.0 in Q1 2025, and down 99.28% quarter-over-quarter from $42.9 million in Q4 2025.
Arcutis Biotherapeutics (ARQT) Cash & Equivalents (2020 - 2026) Analysis & Trends
Arcutis Biotherapeutics' Cash & Equivalents history runs 7 years deep, the most recent figure standing at $308000.0 for Q1 2026.
- In Q1 2026, Cash & Equivalents fell 50.08% year-over-year to $308000.0; the TTM figure through Mar 2026 stood at $308000.0 (down 50.08% YoY), while the FY2025 annual figure was $42.9 million, down 39.85% from the prior year.
- Cash & Equivalents for Q1 2026 stood at $308000.0, down from $42.9 million in the prior quarter.
- The five-year high for Cash & Equivalents was $134.9 million in Q3 2024, with the low at $300000.0 in Q2 2025.
- The 5-year median for Cash & Equivalents is $925000.0 (2023), against an average of $21.6 million.
- The sharpest annual moves came in 2023 and 2024: Cash & Equivalents tumbled 98.54% in 2023, then soared 14883.44% in 2024.
- Arcutis Biotherapeutics' Cash & Equivalents stood at $1.2 million in 2022, then decreased by 25.04% to $925000.0 in 2023, then surged by 7611.89% to $71.3 million in 2024, then slumped by 39.85% to $42.9 million in 2025, then sank by 99.28% to $308000.0 in 2026.
- Business Quant data shows ARQT's Cash & Equivalents at $308000.0 in Q1 2026, $42.9 million in Q4 2025, and $47.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 6.14 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 2.46 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 3.58 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 815.44 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 8.37 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 811.99 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.71 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 544.80 Mn |
| 10 | Arcutis Biotherapeutics | 3.29 Bn | 3.05 Bn | 118.92 Mn | 34.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 34.12 Mn |
| Mar 31, 2026 | 308,000.00 |
| Dec 31, 2025 | 42.91 Mn |
| Sep 30, 2025 | 47.12 Mn |
| Jun 30, 2025 | 300,000.00 |
| Mar 31, 2025 | 617,000.00 |
| Dec 31, 2024 | 71.34 Mn |
| Sep 30, 2024 | 134.85 Mn |
| Jun 30, 2024 | 617,000.00 |
| Mar 31, 2024 | 600,000.00 |
| Dec 31, 2023 | 925,000.00 |
| Sep 30, 2023 | 900,000.00 |
| Jun 30, 2023 | 900,000.00 |
| Mar 31, 2023 | 900,000.00 |
| Dec 31, 2022 | 1.23 Mn |
| Sep 30, 2022 | 1.23 Mn |
| Jun 30, 2022 | 61.51 Mn |
| Mar 31, 2022 | 1.20 Mn |
| Dec 31, 2021 | 1.54 Mn |
| Sep 30, 2021 | 51.78 Mn |